Latticework
← Super investors

NAMS

Newamsterdam Pharma Company

4 super-investor ownerscombined $326Mlargest position 3.3%

Cohort owners over time

2024Q3 2026Q1

How many of the cohort members held this stock each quarter.

Now: 1
Peak: 1

Owners (4) · click any column to sort

Long US equity 13F-HR filings only. CUSIP N62509109. Not investment advice.